These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 29132940)

  • 1. Bullseye's representation of cerebral white matter hyperintensities.
    Sudre CH; Gomez Anson B; Davagnanam I; Schmitt A; Mendelson AF; Prados F; Smith L; Atkinson D; Hughes AD; Chaturvedi N; Cardoso MJ; Barkhof F; Jaeger HR; Ourselin S
    J Neuroradiol; 2018 Mar; 45(2):114-122. PubMed ID: 29132940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of white matter hyperintensities associated with cognition in middle-aged cognitively healthy individuals.
    Brugulat-Serrat A; Salvadó G; Sudre CH; Grau-Rivera O; Suárez-Calvet M; Falcon C; Sánchez-Benavides G; Gramunt N; Fauria K; Cardoso MJ; Barkhof F; Molinuevo JL; Gispert JD;
    Brain Imaging Behav; 2020 Oct; 14(5):2012-2023. PubMed ID: 31278650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Automatic segmentation of white matter hyperintensities: validation and comparison with state-of-the-art methods on both Multiple Sclerosis and elderly subjects.
    Tran P; Thoprakarn U; Gourieux E; Dos Santos CL; Cavedo E; Guizard N; Cotton F; Krolak-Salmon P; Delmaire C; Heidelberg D; Pyatigorskaya N; Ströer S; Dormont D; Martini JB; Chupin M;
    Neuroimage Clin; 2022; 33():102940. PubMed ID: 35051744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of white matter hyperintensities scoring method on correlations with clinical data: the LADIS study.
    van Straaten EC; Fazekas F; Rostrup E; Scheltens P; Schmidt R; Pantoni L; Inzitari D; Waldemar G; Erkinjuntti T; Mäntylä R; Wahlund LO; Barkhof F;
    Stroke; 2006 Mar; 37(3):836-40. PubMed ID: 16439704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can white matter hyperintensities based Fazekas visual assessment scales inform about Alzheimer's disease pathology in the population?
    Pradeep A; Raghavan S; Przybelski SA; Preboske G; Schwarz CG; Lowe VJ; Knopman DS; Petersen RC; Jack CR; Graff-Radford J; Cogswell PM; Vemuri P
    Res Sq; 2024 Mar; ():. PubMed ID: 38558965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. White matter hyperintensities in progranulin-associated frontotemporal dementia: A longitudinal GENFI study.
    Sudre CH; Bocchetta M; Heller C; Convery R; Neason M; Moore KM; Cash DM; Thomas DL; Woollacott IOC; Foiani M; Heslegrave A; Shafei R; Greaves C; van Swieten J; Moreno F; Sanchez-Valle R; Borroni B; Laforce R; Masellis M; Tartaglia MC; Graff C; Galimberti D; Rowe JB; Finger E; Synofzik M; Vandenberghe R; de Mendonça A; Tagliavini F; Santana I; Ducharme S; Butler C; Gerhard A; Levin J; Danek A; Frisoni GB; Sorbi S; Otto M; Zetterberg H; Ourselin S; Cardoso MJ; Rohrer JD;
    Neuroimage Clin; 2019; 24():102077. PubMed ID: 31835286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age-associated leukoaraiosis and cortical cholinergic deafferentation.
    Bohnen NI; Müller ML; Kuwabara H; Constantine GM; Studenski SA
    Neurology; 2009 Apr; 72(16):1411-6. PubMed ID: 19380700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular Risk Factors and White Matter Hyperintensities: Difference in Susceptibility in South Asians Compared With Europeans.
    Sudre CH; Smith L; Atkinson D; Chaturvedi N; Ourselin S; Barkhof F; Hughes AD; Jäger HR; Cardoso MJ
    J Am Heart Assoc; 2018 Nov; 7(21):e010533. PubMed ID: 30376748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measuring longitudinal white matter changes: comparison of a visual rating scale with a volumetric measurement.
    van den Heuvel DM; ten Dam VH; de Craen AJ; Admiraal-Behloul F; van Es AC; Palm WM; Spilt A; Bollen EL; Blauw GJ; Launer L; Westendorp RG; van Buchem MA;
    AJNR Am J Neuroradiol; 2006 Apr; 27(4):875-8. PubMed ID: 16611781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gray matter blood flow and volume are reduced in association with white matter hyperintensity lesion burden: a cross-sectional MRI study.
    Crane DE; Black SE; Ganda A; Mikulis DJ; Nestor SM; Donahue MJ; MacIntosh BJ
    Front Aging Neurosci; 2015; 7():131. PubMed ID: 26217223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simple versus complex assessment of white matter hyperintensities in relation to physical performance and cognition: the LADIS study.
    Gouw AA; Van der Flier WM; van Straaten EC; Barkhof F; Ferro JM; Baezner H; Pantoni L; Inzitari D; Erkinjuntti T; Wahlund LO; Waldemar G; Schmidt R; Fazekas F; Scheltens P;
    J Neurol; 2006 Sep; 253(9):1189-96. PubMed ID: 16998647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. White matter hyperintensity distribution differences in aging and neurodegenerative disease cohorts.
    Dadar M; Mahmoud S; Zhernovaia M; Camicioli R; Maranzano J; Duchesne S;
    Neuroimage Clin; 2022; 36():103204. PubMed ID: 36155321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metric to quantify white matter damage on brain magnetic resonance images.
    Valdés Hernández MDC; Chappell FM; Muñoz Maniega S; Dickie DA; Royle NA; Morris Z; Anblagan D; Sakka E; Armitage PA; Bastin ME; Deary IJ; Wardlaw JM
    Neuroradiology; 2017 Oct; 59(10):951-962. PubMed ID: 28815362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complexity of MRI white matter hyperintensity assessments in relation to cognition in aging and dementia from the Sunnybrook Dementia Study.
    Gao FQ; Swartz RH; Scheltens P; Leibovitch FS; Kiss A; Honjo K; Black SE
    J Alzheimers Dis; 2011; 26 Suppl 3():379-88. PubMed ID: 21971477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Stroke Lesion Pattern and White Matter Hyperintensity Burden With Stroke Severity and Outcome.
    Bonkhoff AK; Hong S; Bretzner M; Schirmer MD; Regenhardt RW; Arsava EM; Donahue K; Nardin M; Dalca A; Giese AK; Etherton MR; Hancock BL; Mocking SJT; McIntosh E; Attia J; Benavente O; Cole JW; Donatti A; Griessenauer C; Heitsch L; Holmegaard L; Jood K; Jimenez-Conde J; Kittner S; Lemmens R; Levi C; McDonough CW; Meschia J; Phuah CL; Rolfs A; Ropele S; Rosand J; Roquer J; Rundek T; Sacco RL; Schmidt R; Sharma P; Slowik A; Soederholm M; Sousa A; Stanne TM; Strbian D; Tatlisumak T; Thijs V; Vagal A; Wasselius J; Woo D; Zand R; McArdle P; Worrall BB; Jern C; Lindgren AG; Maguire J; Golland P; Bzdok D; Wu O; Rost NS
    Neurology; 2022 Sep; 99(13):e1364-e1379. PubMed ID: 35803717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance of three freely available methods for extracting white matter hyperintensities: FreeSurfer, UBO Detector, and BIANCA.
    Hotz I; Deschwanden PF; Liem F; Mérillat S; Malagurski B; Kollias S; Jäncke L
    Hum Brain Mapp; 2022 Apr; 43(5):1481-1500. PubMed ID: 34873789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. White matter hyperintensities and risk of levodopa-induced dyskinesia in Parkinson's disease.
    Chung SJ; Yoo HS; Lee YH; Jung JH; Baik K; Ye BS; Sohn YH; Lee PH
    Ann Clin Transl Neurol; 2020 Feb; 7(2):229-238. PubMed ID: 32032471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebral blood flow by using pulsed arterial spin-labeling in elderly subjects with white matter hyperintensities.
    Bastos-Leite AJ; Kuijer JP; Rombouts SA; Sanz-Arigita E; van Straaten EC; Gouw AA; van der Flier WM; Scheltens P; Barkhof F
    AJNR Am J Neuroradiol; 2008 Aug; 29(7):1296-301. PubMed ID: 18451090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitation of brain tissue changes associated with white matter hyperintensities by diffusion-weighted and magnetization transfer imaging: the LADIS (Leukoaraiosis and Disability in the Elderly) study.
    Ropele S; Seewann A; Gouw AA; van der Flier WM; Schmidt R; Pantoni L; Inzitari D; Erkinjuntti T; Scheltens P; Wahlund LO; Waldemar G; Chabriat H; Ferro J; Hennerici M; O'Brien J; Wallin A; Langhorne P; Visser MC; Barkhof F; Fazekas F;
    J Magn Reson Imaging; 2009 Feb; 29(2):268-74. PubMed ID: 19161174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. White matter hyperintensities: a marker for apathy in Parkinson's disease without dementia?
    Zhang Y; Zhang GY; Zhang ZE; He AQ; Gan J; Liu Z
    Ann Clin Transl Neurol; 2020 Sep; 7(9):1692-1701. PubMed ID: 32857484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.